المؤلفون: Yu. S. Filatova, O. V. Zheltkevich, O. N. Solodchuk, L. A. Kramskaya, Ю. С. Филатова, О. В. Желткевич, О. Н. Солодчук, Л. А. Крамская

المصدر: Meditsinskiy sovet = Medical Council; № 5 (2024); 183-190 ; Медицинский Совет; № 5 (2024); 183-190 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: хондроитина сульфат, osteoarthritis, patient’s personality, social factors, osteoarthritis therapy, injection forms, chondroitin sulfate, остеоартрит, личность пациента, социальные факторы, терапия остеоартрита, инъекционные формы

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/8237/7260; Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T et al ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. https://doi.org/10.1111/j.1365-2125.2012.04167.x.; Gellad WF, Thorpe CT, Steiner JF, Voils CI. The myths of medication adherence. Pharmacoepidemiol Drug Saf. 2017;26(12):1437–1441. https://doi.org/10.1002/pds.4334.; van den Bemt BJ, Zwikker HE, van den Ende CH. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol. 2012;8(4):337–351. https://doi.org/10.1586/eci.12.23.; DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–811. https://doi.org/10.1097/00005650-200209000-00009.; Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155–159. https://doi.org/10.5001/omj.2011.38.; Jaam M, Awaisu A, Mohamed Ibrahim MI, Kheir N. A holistic conceptual framework model to describe medication adherence in and guide inter ventions in diabetes mellitus. Res Social Adm Pharm. 2018;14(4):391–397. https://doi.org/10.1016/j.sapharm.2017.05.003.; Oori MJ, Mohammadi F, Norouzi K, Fallahi-Khoshknab M, Ebadi A. Conceptual Model of Medication Adherence in Older Adults with High Blood Pressure-An Integrative Review of the Literature. Curr Hypertens Rev. 2019;15(2):85–92. https://doi.org/10.2174/1573402114666181022152313.; Wilder ME, Kulie P, Jensen C, Levett P, Blanchard J, Dominguez LW et al The Impact of Social Determinants of Health on Medication Adherence: a Systematic Review and Meta-analysis. J Gen Intern Med. 2021;36(5):1359–1370. https://doi.org/10.1007/s11606-020-06447-0.; Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109. https://doi.org/10.1016/j.clinthera.2011.01.019.; Han E, Suh D, Lee S, Jang S. The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study. Res Social Adm Pharm. 2014;10(6):87–98. https://doi.org/10.1016/j.sapharm.2014.02.001.; Lee S, Raamkumar AS, Li J, Cao Y, Witedwittayanusat K, Chen L, Theng Y. Reasons for primary medication nonadherence: a systematic review and metric analysis. J Manag Care Spec Pharm. 2018;24(8):778–794. https://doi.org/10.18553/jmcp.2018.24.8.778.; Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF et al Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–1841. https://doi.org/10.1001/archinte.166.17.1836; Dal-Fabbro AL. Adherence to long term therapies: evidence for action. Cad Saúde Pública. 2005;21(4):1297–1298. https://doi.org/10.1590/s0102-311x2005000400037.; Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2):CD000011. https://doi.org/10.1002/14651858.CD000011.pub3.; Brown M, Bussell J. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–314. https://doi.org/10.4065/mcp.2010.0575.; Yao Q, Wu X, Tao C, Gong W, Chen M, Qu M et al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):56. https://doi.org/10.1038/s41392-023-01330-w.; Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: A review. JAMA. 2021;325:568–578. https://doi.org/10.1001/jama.2020.22171.; Richard MJ, Driban JB, McAlindon TE. Pharmaceutical treatment of osteoarthritis. Osteoarthritis Cartilage. 2023;31(4):458–466. https://doi.org/10.1016/j.joca.2022.11.005.; Oo WM, Yu SP, Daniel MS, Hunter DJ. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics. Expert Opin Emerg Drugs. 2018;23(4):331–347. https://doi.org/10.1080/14728214.2018.1547706.; Punchak S, Goodyer LI, Miskelly F. Use of an electronic monitoring aid to investigate the medication pattern of analgesics and non-steroidal anti-inflammatory drugs prescribed for osteoarthritis. Rheumatology (Oxford). 2000;39(4):448–449. https://doi.org/10.1093/rheumatology/39.4.448.; Blamey R, Jolly K, Greenfield S, Jobanputra P. Patterns of analgesic use, pain and self-efficacy: a cross-sectional study of patients attending a hospital rheumatology clinic. BMC Musculoskelet Disord. 2009;10:137. https://doi.org/10.1186/1471-2474-10-137.; Salt E, Peden A. The complexity of the treatment: the decision-making process among women with rheumatoid arthritis. Qual Health Res. 2011;21(2):214–222. https://doi.org/10.1177/1049732310381086.; Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud. 2007;44(8):1468–1477. https://doi.org/10.1016/j.ijnurstu.2006.07.010.; Sale JE, Gignac M, Hawker G. How “bad” does the pain have to be? A qualitative study examining adherence to pain medication in older adults with osteoarthritis. Arthritis Rheum. 2006;55(2):272–278. https://doi.org/10.1002/art.21853.; Milder TY, Lipworth WL, Williams KM, Ritchie JE, Day RO. “It looks after me”: how older patients make decisions about analgesics for osteoarthritis. Arthritis Care Res (Hoboken). 2011;63(9):1280–1286. https://doi.org/10.1002/acr.20514.; Milder TY, Williams KM, Ritchie JE, Lipworth WL, Day RO. Use of NSAIDs for osteoarthritis amongst older-aged primary care patients: engagement with information and perceptions of risk. Age Ageing. 2011;40(2):254–259. https://doi.org/10.1093/ageing/afq160.; Ratcliffe J, Buxton M, McGarry T, Sheldon R, Chancellor J. Patients’ preferences for characteristics associated with treatments for osteoarthritis. Rheumatology (Oxford). 2004;43(3):337–345. https://doi.org/10.1093/rheumatology/keh038.; Laba TL, Brien JA, Fransen M, Jan S. Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS). BMC Musculoskelet Disord. 2013;14:160. https://doi.org/10.1186/1471-2474-14-160.; Hofstede SN, Marang-van de Mheen PJ, Vliet Vlieland TP, van den Ende CH, Nelissen RG, van Bodegom-Vos L. Barriers and Facilitators Associated with Non-Surgical Treatment Use for Osteoarthritis Patients in Orthopaedic Practice. PLoS ONE. 2016;11(1):0147406. https://doi.org/10.1371/journal.pone.0147406.; Hoogeboom TJ, Snijders GF, Cats HA, de Bie RA, Bierma-Zeinstra SM, van den Hoogen FH et al. Prevalence and predictors of health care use in patients with early hip or knee osteoarthritis: two-year follow-up data from the CHECK cohort. Osteoarthritis Cartilage. 2012;20(6):525–531. https://doi.org/10.1016/j.joca.2012.03.003.; Cavazos JM, Naik AD, Woofter A, Abraham NS. Barriers to physician adherence to nonsteroidal anti-inflammatory drug guidelines: a qualitative study. Aliment Pharmacol Ther. 2008;28(6):789–798. https://doi.org/10.1111/j.1365-2036.2008.03791.x.; Hofstede SN, van Bodegom-Vos L, Wentink MM, Vleggeert-Lankamp CL, Vliet Vlieland TP, Marang-van de Mheen PJ. Most important factors for the implementation of shared decision making in sciatica care: ranking among professionals and patients. PLoS ONE. 2014;9(4):e94176. https://doi.org/10.1371/journal.pone.0094176.; Замятина ЕА, Багирова ГГ, Цурко ВВ. Остеоартроз: ведение пациентов с учетом коморбидности и приверженности к лечению. Практикующий врач сегодня. 2014;(2-3):21–30. Режим доступа: https://www.elibrary.ru/xbwrnd.; Carmona-Terés V, Moix-Queraltó J, Pujol-Ribera E, Lumillo-Gutiérrez I, Mas X, Batlle-Gualda E et al. Understanding knee osteoarthritis from the patients’ perspective: a qualitative study. BMC Musculoskelet Disord. 2017;18(1):225. https://doi.org/10.1186/s12891-017-1584-3.; Иванова АВ, Даудова ПГ, Оптовко ДА. Социально-демографические, психологические и клинические факторы, влияющие на приверженность к терапии у пациентов с остеоартритом и коморбидными заболеваниями. В: Вебер ВР, Сулиманов РА (ред.). Актуальные проблемы современной медицины: сборник научных статей по материалам XXVI научно-практической конференции сотрудников и студентов Института медицинского образования Новгородского государственного университета имени Ярослава Мудрого, Великий Новгород, 8–13 апреля 2019 г. Великий Новгород: Новгородский государственный университет имени Ярослава Мудрого; 2019. 264 с. Режим доступа: https://elibrary.ru/item.asp?edn=iazrsl.; Swain S, Sarmanova A, Coupland C, Doherty M, Zhang W. Comorbidities in Osteoarthritis: A Systematic Review and Meta-Analysis of Observational Studies. Arthritis Care Res (Hoboken). 2020;72(7):991–1000. https://doi.org/10.1002/acr.24008.; Kovari E, Kaposi A, Bekes G, Kiss Z, Kurucz R, Mandl P et al. Comorbidity clusters in generalized osteoarthritis among female patients: A crosssectional study. Semin Arthritis Rheum. 2020;50(2):183–191. https://doi.org/10.1016/j.semarthrit.2019.09.001.; Agustini B, Lotfaliany M, Woods RL, McNeil JJ, Nelson MR, Shah RC et al. Patterns of Association between Depressive Symptoms and Chronic Medical Morbidities in Older Adults. J Am Geriatr Soc. 2020;68(8):1834–1841. https://doi.org/10.1111/jgs.16468.; Филатова ЮС, Соловьев ИН. Пациент с остеоартритом коленных суставов: тактика ведения в амбулаторных условиях. Медицинский совет. 2021;(2):86–93. https://doi.org/10.21518/2079-701X-2021-2-86-93.; Филатова ЮС, Соловьев ИН. Некоторые аспекты противовоспалительной терапии остеоартрита. Медицинский совет. 2023;17(13):157–164. https://doi.org/10.21518/ms2023-251.; Аникин СГ, Алексеева ЛИ. Хондроитина сульфат: механизмы действия, эффективность и безопасность при терапии остеоартроза. Современная ревматология. 2012;6(3):78–82. https://doi.org/10.14412/1996-7012-2012-753.; Ho J, Mak CCH, Sharma V, To K, Khan W. Mendelian Randomization Studies of Lifestyle-Related Risk Factors for Osteoarthritis: A PRISMA Review and Meta-Analysis. Int J Mol Sci. 2022;23(19):11906. https://doi.org/10.3390/ijms231911906.; Chen X, Hu JG, Huang YZ, Li S, Li SF, Wang M et al. Copper promotes the migration of bone marrow mesenchymal stem cells via Rnd3- dependent cytoskeleton remodeling. J Cell Physiol. 2020;235(1):221–231. https://doi.org/10.1002/jcp.28961.; Yassin NZ, El-Shenawy SM, Abdel-Rahman RF, Yakoot M, Hassan M, Helmy S. Effect of a topical copper indomethacin gel on inflammatory parameters in a rat model of osteoarthritis. Drug Des Devel Ther. 2015;9:1491–1498. https://doi.org/10.2147/DDDT.S79957.; Roczniak W, Brodziak-Dopierała B, Cipora E, Jakóbik-Kolon A, Kluczka J, Babuśka-Roczniak M. Factors that affect the content of cadmium, nickel, copper and zinc in tissues of the knee joint. Biol Trace Elem Res. 2017;178(2):201–209. https://doi.org/10.1007/s12011-016-0927-5.; Xu C, Chen J, Li L, Pu X, Chu X, Wang X et al. Promotion of chondrogenic differentiation of mesenchymal stem cells by copper: implications for new cartilage repair biomaterials. Mater Sci Eng C Mater Biol Appl. 2018;93:106–114. https://doi.org/10.1016/j.msec.2018.07.074.; Kot K, Kosik-Bogacka D, Zietek P, Karaczun M, Ciosek Z, Łanocha-Arendarczyk N. Impact of varied factors on iron, nickel, molybdenum and vanadium concentrations in the knee joint. Int J Environ Res Public Health. 2020;17(3):813. https://doi.org/10.3390/ijerph17030813.; Díaz-Castro J, López-Frías MR, Campos MS, López-Frías M, Alférez MJ, Nestares T et al. Severe nutritional iron-deficiency anaemia has a negative effect on some bone turnover biomarkers in rats. Eur J Nutr. 2012;51(2):241–247. https://doi.org/10.1007/s00394-011-0212-5.; Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial. Arch Med Res. 2014;45(4):325–330. https://doi.org/10.1016/j.arcmed.2014.04.006.; Konstari S, Sares-Jäske L, Heliövaara M, Rissanen H, Knekt P, Arokoski J et al. Dietary magnesium intake, serum high sensitivity C-reactive protein and the risk of incident knee osteoarthritis leading to hospitalization-A cohort study of 4,953 Finns. PLoS ONE. 2019;14(3):e0214064. https://doi.org/10.1371/journal.pone.0214064.; Belluci MM, de Molon RS, Rossa CJr, Tetradis S, Giro G, Cerri PS et al. Severe magnesium deficiency compromises systemic bone mineral density and aggravates inflammatory bone resorption. J Nutr Biochem. 2020;77:108301. https://doi.org/10.1016/j.jnutbio.2019.108301.; Feyerabend F, Witte F, Kammal M, Willumeit R. Unphysiologically high magnesium concentrations support chondrocyte proliferation and redifferentiation. Tissue Eng. 2006;12(12):3545–3556. https://doi.org/10.1089/ten.2006.12.3545.; Rył A, Miazgowski T, Szylińska A, Turoń-Skrzypińska A, Jurewicz A, Bohatyrewicz A et al. Bone health in aging men: does zinc and cuprum level matter? Biomolecules. 2021;11(2):237. https://doi.org/10.3390/biom11020237.; Khader A, Arinzeh TL. Biodegradable zinc oxide composite scaffolds promote osteochondral differentiation of mesenchymal stem cells. Biotechnol Bioeng. 2020;117(1):194–209. https://doi.org/10.1002/bit.27173.; Rodríguez JP, Rosselot G. Effects of zinc on cell proliferation and proteoglycan characteristics of epiphyseal chondrocytes. J Cell Biochem. 2001;82(3):501–511. https://doi.org/10.1002/jcb.1178.; https://www.med-sovet.pro/jour/article/view/8237

الاتاحة: https://www.med-sovet.pro/jour/article/view/8237
https://doi.org/10.21518/ms2024-118